Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae-Reference-Cited by-同舟云学术

Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae

Published:2019-03-20 Issue:7 Volume:74 Page:1820-1824
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Ebeyan Samantha¹,Windsor Madeline¹,Bordin Amanda²,Mhango Lebogang²,Erskine Simon¹,Trembizki Ella²,Mokany Elisa¹,Tan Lit Yeen¹,Whiley David²³,Guy Rebecca,Wand Handan,Donovan Basil,Bell Stephen,Kaldor John,Kong Marlene,Conway Damian,Lafferty Lise,Ward James,Lahra Monica,Chen Marcus,Ryder Nathan,Lewis David,Paterson David,Trembizki Ella,Baird Robert,Fairley Christopher,Gunathilake Manoji,Howden Ben,Klausner Jeff,Nimmo Graeme,Russell Darren,Menon Arun,Palmer Cheryn,McNulty Anna,Templeton David,Cunningham Philip,van Hal Sebastian,Givney Rodney,

Affiliation:

1. SpeeDx Pty Ltd, Sydney, New South Wales, Australia

2. Faculty of Medicine, Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia

3. Pathology Queensland Central Laboratory, Brisbane, Queensland, Australia

Funder

National Health and Medical Research Council

NHMRC fellowship

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link